Man

Mario I Fernandez Arancibia

Associate Professor

CLÍNICA ALEMANA DE SANTIAGO

Santiago, Chile

Líneas de Investigación


Translational research in urothelial cancer- molecular mechanisms, markers, early detection, natural history, treatment, and outcomes research; Minimal invasive treatment modalities for urolithiasis and upper tract malignant diseases

Educación

  •  Medico Cirujano, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Chile, 2001
  •  Urólogo, UNIVERSIDAD DE CHILE. Chile, 2004
  •  Urology, UNIVERSITAT HEIDELBERG. Alemania, 2007

Experiencia Académica

  •   Researcher - Associate Professor Other

    Clínica Alemana Universidad del Desarrollo

    Medicine

    Santiago, Chile

    2011 - A la fecha

  •   Adjunct Instructor Other

    UNIVERSIDAD DE CHILE

    Medicine

    Santiago, Chile

    2004 - 2008

  •   Visiting Scientist Full Time

    UNIV TEXAS M.D. ANDERSON CANCER CENTER

    Houston, Estados Unidos

    2012 - 2012

Experiencia Profesional

  •   Faculty - Urology Part Time

    Hospital San José

    Santiago, Chile

    2003 - 2008

  •   Faculty - Urology Part Time

    Hospital Militar de Santiago

    Santiago, Chile

    2005 - 2011

  •   Visiting Physician Full Time

    Universitätsklinikum Mannheim

    Mannheim, Alemania

    2005 - 2006

Premios y Distinciones

  •   Best Abstract

    SOCIEDAD CHILENA DE UROLOGIA

    Chile, 2011

    Best Abstract at the XXXIII Chilean Congress of Urology "Expresión de proteínas de vía de reparación de ADN por escisión de nucleótidos en cáncer urotelial de vejiga: relación con status tabáquico y variables clinicopatológicas"

  •   Best Video

    SOCIEDAD CHILENA DE UROLOGIA

    Chile, 2011

    Best Video at the XXXIII Chilean Congress of Urology "Dificultades y complicaciones intraoperatorias en Ureterorrenoscopía"

  •   Best Abstract

    SOCIEDAD CHILENA DE UROLOGIA

    Chile, 2015

    Best Abstract at the XXXVII Chilean Congress of Urology "Asociación de variantes genéticas con la ocurrencia de cáncer de vejiga en una población expuesta a arsénico. Resultados de un estudio asociado del genoma completo"

  •   Best Abstract

    SOCIEDAD CHILENA DE UROLOGIA

    Chile, 2018

    Best Abstract at the XL Chilean Congress of Urology "Identificación de variantes genéticas asociadas a adaptación selectiva en una población expuesta a arsénico!

  •   Third best Abstract

    Deutsche Gesellschaft für Urologie

    Alemania, 2006

    Third Best Abstract at the Annual DGU Meeting 2006 "A new long-term 3D tissue culture model of benign urothelium and transitional cell carcinoma with evaluation of topical chemotherapy"


 

Article (46)

A prospective randomized study comparing bipolar plasmakinetic transurethral resection of the prostate and monopolar transurethral resection of the prostate for the treatment of Benign Prostatic Hyperplasia: efficacy, sexual function, Quality of Life, and complications
Arsenic exposure is associated with significant upper tract urothelial carcinoma health care needs and elevated mortality rates
Impact of arsenic exposure on clinicopathological characteristics of bladder cancer: A comparative study between patients from an arsenic-exposed region and nonexposed reference sites
Post-Admixture Selection on Chileans Targets Haplotype Involved in Pigmentation and Immune Defense Against Pathogens
Adaptation to Extreme Environments in an Admixed Human Population from the Atacama Desert
Epidemiology, prevention, screening, diagnosis, and evaluation=> update of the ICUD-SIU joint consultation on bladder cancer.
Prevalence of Chlamydia Trachomatis, Neisseria Gonorrhoeae, and Trichomonas Vaginalis Infection in Chilean Adolescents and Young Adults.
[Adolescents find it easy to collect their own samples to study sexually transmitted infections].
Clinical risk stratification in patients with surgically resectable micropapillary bladder cancer.
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC).
Upper Urinary Tract Carcinoma In Situ=> Current Knowledge, Future Direction.
Hemostatic agents for access tract in tubeless percutaneous nephrolithotomy: Is it worth?
Advances in the treatment of castration-resistant prostate cancer: Emphasis in new hormonal therapies [Avances en el tratamiento de cancer de próstata resistente a la castración: énfasis en nuevas terapias hormonales]
Clinical outcomes of cT1 micropapillary bladder cancer.
Immediate postoperative morbidity in patients with indwelling double-J stent versus overnight-externalized ureteral catheter after tubeless percutaneous nephrolithotomy: a prospective, randomized study
γ-H2AX level in peripheral blood lymphocytes as a risk predictor for bladder cancer
Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy.
Long-Term Impact of Arsenic in Drinking Water on Bladder Cancer Health Care and Mortality Rates 20 Years After End of Exposure
The role of FISH and cytology in upper urinary tract surveillance after radical cystectomy for bladder cancer.
Additive antitumoral effect of interleukin-12 gene therapy and chemotherapy in the treatment of urothelial bladder cancer in vitro and in vivo
Postoperative morbidity of tubeless versus conventional percutaneous nephrolithotomy: a prospective comparative study
Single-Session Extracorporeal Shock Wave Lithotripsy for Urinary Calculi: Factors Predicting Success after Three Weeks of Follow-Up
Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy.
Tumour Necrosis Is an Indicator of Aggressive Biology in Patients with Urothelial Carcinoma of the Upper Urinary Tract
Adjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma: Results From the Upper Tract Urothelial Carcinoma Collaboration
Assessment of the Minimum Number of Lymph Nodes Needed to Detect Lymph Node Invasion at Radical Nephroureterectomy in Patients With Upper Tract Urothelial Cancer
Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases.
Evidence-based Sex-related Outcomes After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: Results of Large Multicenter Study
Impact of Lymph Node Dissection on Cancer Specific Survival in Patients With Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy
Lymphangiogenesis occurs in upper tract urothelial carcinoma and correlates with lymphatic tumour dissemination and poor prognosis
Lymphovascular Invasion Predicts Clinical Outcomes in Patients With Node-Negative Upper Tract Urothelial Carcinoma
Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density
The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed?
The role of lymphangiogenesis in lymphatic tumour spread of urological cancers.
Topical Chemotherapy in Human Urothelial Carcinoma Explants: A Novel Translational Tool for Preclinical Evaluation of Experimental Intravesical Therapies
Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients.
Lymphovascular invasion and pathologic tumor stage are significant outcome predictors for patients with upper tract urothelial carcinoma
Prognostic implications of lymphangiogenesis in muscle-invasive transitional cell carcinoma of the bladder.
Newly developed mini-endoscope for diagnosis and follow-up of orthotopic bladder transitional-cell carcinoma in vivo.
The modern management of upper tract urothelial cancer: surgical treatment.
Intravesical mitomycin C for superficial transitional cell carcinoma.
[Coronary artery surgery in the first 24 hours after myocardial infarction].
Coronary artery surgery in the first 24 hours after myocardial infarction
Coronary artery bypass grafting reoperation. A 16 years retrospective analysis
[Diagnosis and therapeutic options for prolonged erection and priapism: up-date review].
[Influence of Professor Alexander von Lichtenberg (Berlin) on Spanish urology of the 20th century].

Proyecto (4)

Determinantes genéticas asociadas al pronóstico clínico de pacientes con cáncer de vejiga con exposición a arsénico
Clinical Significance of PD-L1 Protein expression and Tumor Infiltrating Lymphocytes in Early Stage Urothelial Bladder Carcinoma”
DESARROLLO DE LÍNEAS CELULARES DE CÁNCER DE VEJIGA RELACIONADO A EXPOSICIÓN A ARSÉNICO
ASSESSMENT OF A PANEL OF MOLECULAR BIOMARKERS AS PREDICTORS OF TUMOR RECURRENCE AND PROGRESSION IN NON-MUSCLE INVASIVE BLADDER CANCER

Review (1)

What Is the Significance of Variant Histology in Urothelial Carcinoma?
16
Mario Fernandez

Associate Professor

Urology

CLÍNICA ALEMANA DE SANTIAGO

Santiago, Chile

2
Maria Vial

Associate Professor/Profesor Asociado

Instituto de Ciencias e Innovación de Medicina

UNIVERSIDAD DEL DESARROLLO

Santiago, Chile

2
Ramon Corbalan

Director

Division of Cardiovascular Diseases

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

SANTIAGO, Chile

1
Orozimba Delgado

Profesor Asociado

Facultad de Medicina Clinica Alemana Universidad del Desarrollo

UNIVERSIDAD DEL DESARROLLO

Santiago, Chile